Fosun Pharma targets global expansion for Chinese pharmaceutical products
CEO Chen Qiyu announced a strategy to increase the international availability of affordable medicine at the Sustainability Global Leaders Conference 2026.
Speaking at the Sustainability Global Leaders Conference 2026 in Shanghai, Fosun Pharma CEO Chen Qiyu outlined the company’s intent to broaden the international reach of its pharmaceutical portfolio. The strategy centers on the dual focus of providing affordable and reliable medical treatments to global markets.
The initiative aims to leverage Fosun Pharma’s manufacturing scale and supply chain management to improve access to medication in emerging markets. Chen noted that the firm's growth trajectory is tied to its ability to align localized industrial innovation with the needs of diverse healthcare systems.
Moving forward, the company intends to navigate international regulatory landscapes by establishing partnerships that facilitate easier entry into new territories. Fosun Pharma aims to solidify its status as a key competitor by maintaining consistent product reliability while scaling its distribution network.